Overview

Safety and Efficacy Study of SHAPE Gel in Alopecia Areata

Status:
Unknown status
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of SHAPE Gel applied topically to adult patients with alopecia areata of the scalp.
Phase:
Phase 2
Details
Lead Sponsor:
TetraLogic Pharmaceuticals
Treatments:
Histone Deacetylase Inhibitors